ScoreWhy is OncoTherapy Science, Inc. ?
1
Poor Management Efficiency with a low ROE of 0%
- The company has reported losses. Due to this company has reported negative ROE
2
Positive results in Jun 25
- NET SALES(Q) At JPY 201.49 MM has Grown at 100.06%
- NET PROFIT(HY) Higher at JPY -413.79 MM
- ROCE(HY) Highest at -91.98%
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -29.03%, its profits have risen by 28.7%
4
Below par performance in long term as well as near term
- Along with generating -29.03% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to OncoTherapy Science, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is OncoTherapy Science, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
OncoTherapy Science, Inc.
-29.03%
-0.06
71.96%
Japan Nikkei 225
28.54%
1.14
25.81%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
18.86%
EBIT Growth (5y)
10.23%
EBIT to Interest (avg)
-1,319.44
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.07
Sales to Capital Employed (avg)
0.97
Tax Ratio
0.27%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.57
EV to EBIT
-6.70
EV to EBITDA
-6.70
EV to Capital Employed
-101.76
EV to Sales
7.29
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-112.08%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend21What is working for the Company
NET SALES(Q)
At JPY 201.49 MM has Grown at 100.06%
NET PROFIT(HY)
Higher at JPY -413.79 MM
ROCE(HY)
Highest at -91.98%
RAW MATERIAL COST(Y)
Fallen by -92.6% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -110.17 %
DEBTORS TURNOVER RATIO(HY)
Highest at 21.09%
-11What is not working for the Company
INTEREST(HY)
At JPY 0.65 MM has Grown at 100%
OPERATING PROFIT(Q)
Lowest at JPY -303.93 MM
PRE-TAX PROFIT(Q)
Lowest at JPY -313.82 MM
NET PROFIT(Q)
Lowest at JPY -314.37 MM
Here's what is working for OncoTherapy Science, Inc.
Net Sales
At JPY 201.49 MM has Grown at 100.06%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely positive
Net Sales (JPY MM)
Debt-Equity Ratio
Lowest at -110.17 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 21.09%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -92.6% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for OncoTherapy Science, Inc.
Interest
At JPY 0.65 MM has Grown at 100%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Operating Profit
Lowest at JPY -303.93 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (JPY MM)
Pre-Tax Profit
Lowest at JPY -313.82 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (JPY MM)
Net Profit
Lowest at JPY -314.37 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (JPY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
